| docetaxel / Generic mfg. |
NCT00004066: Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma |
|
|
| Completed | 2 | 82 | US | filgrastim, docetaxel, gemcitabine hydrochloride | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Ovarian Cancer, Sarcoma, Small Intestine Cancer | 10/03 | 10/03 | | |
NCT00002825: Docetaxel in Treating Children With Recurrent Solid Tumors |
|
|
| Completed | 2 | 20 | US, Canada, RoW | filgrastim, docetaxel | National Cancer Institute (NCI) | Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma | 12/04 | | | |
NCT00101127: Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma |
|
|
| Completed | 2 | | US | filgrastim, pegfilgrastim, docetaxel, gemcitabine hydrochloride | Gynecologic Oncology Group, National Cancer Institute (NCI) | Sarcoma | 07/06 | | | |
NCT00031629: Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus |
|
|
| Completed | 2 | 51 | US | Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Filgrastim, Filgrastim XM02, Filgrastim-sndz, G-CSF, Neupogen, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, rG-CSF, Tbo-filgrastim, Tevagrastim, Zarxio, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, LY188011, Pegfilgrastim, Filgrastim SD-01, filgrastim-SD/01, HSP-130, Neulasta, Neulastim, Pegfilgrastim Biosimilar HSP-130, SD-01, SD-01 sustained duration G-CSF | Gynecologic Oncology Group, National Cancer Institute (NCI) | Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma | 07/07 | | | |
NCT00073983: Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma |
|
|
| Completed | 2 | 54 | US | filgrastim, pegfilgrastim, docetaxel, gemcitabine hydrochloride, microarray analysis, laboratory biomarker analysis, pharmacokinetic study | Sarcoma Alliance for Research through Collaboration | Sarcoma | 01/10 | 12/10 | | |
NCT00227669: Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma |
|
|
| Completed | 2 | 90 | Europe | docetaxel, gemcitabine hydrochloride | UNICANCER | Sarcoma | 02/10 | 08/12 | | |
NCT00359333: Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST |
|
|
| Completed | 2 | 58 | RoW | Gemcitabine , Docetaxel | National Health Research Institutes, Taiwan, Mackay Memorial Hospital, Tri-Service General Hospital, China Medical University Hospital, Kaohsiung Veterans General Hospital., Taichung Veterans General Hospital, Buddhist Tzu Chi General Hospital | Sarcoma, Malignant Gastrointestinal Stromal Tumor | 04/10 | 03/11 | | |
NCT00114218: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer |
|
|
| Completed | 2 | 28 | US | Gemcitabine Hydrochloride, dFdC, dFdCyd, Docetaxel, TXT | Gynecologic Oncology Group, National Cancer Institute (NCI) | Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma | 07/10 | | | |
NCT00282087: Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma |
|
|
| Completed | 2 | 47 | US | gemcitabine, docetaxel, doxorubicin | Sarcoma Alliance for Research through Collaboration | Leiomyosarcoma, Uterine Neoplasm | 01/12 | 01/12 | | |
NCT00189137: Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma |
|
|
| Completed | 2 | 84 | US | ifosfamide and doxorubicin vs gemcitabine and docetaxel | University of Michigan Rogel Cancer Center | Sarcoma, Soft Tissue | 11/12 | 10/15 | | |
NCT00887809: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes |
|
|
| Completed | 2 | 47 | US | gemcitabine, docetaxel, bevacizumab | Memorial Sloan Kettering Cancer Center, Genentech, Inc. | Sarcoma, Leiomyosarcoma, Malignant Fibrous, Histiocytoma, Angiosarcoma | 10/14 | 11/14 | | |
| Completed | 2 | 168 | Europe | gemcitabine + docetaxel, Gemzar, Taxotere, trabectedin, Yondelis | Mario Negri Institute for Pharmacological Research, PharmaMar | Leiomyosarcoma | 04/17 | 04/17 | | |
| Completed | 2 | 43 | Europe | Chemotherapy, Surgery, Radiotherapy | Grupo Espanol de Investigacion en Sarcomas | Ewing's Sarcoma | 12/17 | 01/18 | | |
NCT01491594: Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia |
|
|
| Terminated | 1/2 | 1 | US | Eltrombopag, Promacta | Duke University, GlaxoSmithKline | Sarcoma, Soft Tissue, Osteosarcoma, Neoplasms, Connective and Soft Tissue | 03/13 | 03/13 | | |
NCT01719302: Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma |
|
|
| Completed | 1/2 | 6 | US | Gemcitabine, Gemzar, Docetaxel, Taxotere, Pazopanib, Votrient | University of Vermont, Novartis | Stage III Adult Soft Tissue Sarcoma | 04/15 | 04/15 | | |
NCT01418001: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) |
|
|
| Terminated | 1/2 | 5 | US | Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination | Memorial Sloan Kettering Cancer Center, National Comprehensive Cancer Network, University of California, Los Angeles, Washington University School of Medicine, Northwestern University | Sarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Malignant Fibrous, Histiocytoma/Undifferentiated Pleomorphic Sarcoma | 11/15 | 11/15 | | |
